A recent meta-analysis of randomized controlled trials (RCTs), including AMPLITUDE-O, examining six GLP-1 receptor agonists (lixisenatide, liraglutide, subcutaneous semaglutide, exenatide, dulaglutide, and efpeglenatide) reported a 21% reduction in a composite kidney outcome (macroalbuminuria, doubling of serum creatinine or 40% eGFR decline, RRT, or death from kidney disease), corresponding to a number needed to treat of 47 [73]
Take the Next Step Toward Better Health Schedule an informational consultation with our weight loss clinic for Grandville residents today and explore your personalized plan, without pressure or commitment.
That REDEFINE 4 miss was a significant moment
Waist circumference and waist-to-hip ratio provide supplementary tracking metrics
This allows any medication still in your oral cavity to make contact with the buccal membranes along your cheeks and gums, which also have some absorptive capacity
This is a massive win for patient quality of lifewe aren't just treating a number on a scale